A Phase II Study of M2951 in Systemic Lupus Erythematosus

The purpose of the study is to assess the Safety and Efficacy of M2951 in Subjects with Systemic Lupus Erythematosus (SLE). M2951 is an investigational drug under evaluation for treatment of autoimmune and inflammatory disorders.

To Learn More Contact
US Medical Information at 888-275-7376
ClinicalTrials.gov identifier: NCT02975336

Sign up for our Newsletter

Use this tool to search all lupus trials and create a personalized list of studies by the type of lupus you have and where you live.

Sign up